Jigang Zhang, mainly engaged in the discovery, optimization and application of anti-tumor lead compounds; Early clinical research of innovative drugs; Cell therapy clinical research and management research.

He presided and participated in numbers of national, municipal, and bureau level project of natural science foundation, and published 18 SCI papers as the first author and corresponding author (with the highest impact factor of 18.9 points). In 2014, he won the National Scholarship for Doctoral Students, the second prize of the 14th National Conference on Clinical Pharmacology, and the Youth Outstanding Paper Award at the 15th Annual Conference of the Shanghai Pharmacological Society. In 2015, he won the third prize of excellent paper of the clinical pharmacy branch of Shanghai Medical Association, and the youth excellent paper award of the 16th academic annual meeting of Shanghai Pharmacological Society. In 2018, he gained Excellent Poster Presentation of 18th World Congress of Basic and Clinical Pharmacology (Japan); In 2019, he statemented at The 7th Asia-Pacific Hepatobiliary and Pancreatic Association International Conference (Korea).